Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

King’s College London

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Portfolio companies 1
Rounds per year 0.01
Lead investments 0
Key employees Soon
http://kcl.ac.uk/
London, England, United Kingdom

Areas of investment

  • Health Diagnostics
  • Therapeutics
  • Health Care
  • Biotechnology
Look at other 50 related and similar funds Collapse list ↓
Fund NameLocation
Aether Systems United States, Vienna, Virginia
Aurora Cannabis Alberta, Canada, Cremona
Banques Populaires France, Ile-de-France, Montigny-le-bretonneux
FFP Holdings France, Ile-de-France, Paris
Fosun Ventures -
Halocare Gauteng, NA - South Africa, South Africa
Hubei Liuchao Touzi Guanli Zhongxin China, Huangshi, Hubei
Jidian International Beijing, Beijing, China
LDH JAPAN Japan, Shinagawa
Ola India, Karnataka, Kormangala
Oxeon Partners New York, New York, United States
San Francisco Equity Partners California, San Francisco, United States
Swiss RE Switzerland, Zürich, Zurich
Thin Air Labs Alberta, Calgary, Canada
Thoma Bravo Chicago, Illinois, United States
TNN Capital Luxembourg, Luxembourg
V-Capital China, Shanghai
V8 Capital Partners Ebène, Mauritius, Plaines Wilhems
Vituity California, Emeryville, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Health Care
Health Diagnostics
Therapeutics
16 Sep 2016
Abingworth
The Francis Crick Institute
Cancer Research Technology
King's College London
 London, England, United Kingdom
By posting comments on our website you confirm and acknowledge that:

1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.

2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.

3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.

4. We can moderate comments at any time.

5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.

6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.

Agree

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent King’s College London?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Rounds per year 0.01
Peak activity year 2016
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Health Care
Health Diagnostics
Therapeutics
16 Sep 2016
Abingworth
The Francis Crick Institute
Cancer Research Technology
King's College London
 London, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors:

Send